Yield10 Bioscience logo

Yield10 BioscienceNASDAQ: YTEN

Profile

Country:

United States

IPO:

10 November 2006

Next earnings report:

14 November 2024

Last dividends:

N/A

Next dividends:

N/A
$387.75 K
-98%vs. 3y high
1%vs. sector
-vs. 3y high
-vs. sector
-100%vs. 3y high
6%vs. sector
-99%vs. 3y high
17%vs. sector

Price

regular market | Mon, 04 Nov 2024 14:30:00 GMT
$0.59+$0.02(+3.51%)

Dividend

No data over the past 3 years
$450.00 K$300.00 K
$450.00 K-$3.24 M

Analysts recommendations

Institutional Ownership

YTEN Latest News

Yield10 Bioscience Announces Second Quarter 2024 Financial Results
globenewswire.com14 August 2024 Sentiment: NEUTRAL

WOBURN, Mass., Aug. 14, 2024 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN) ("Yield10" or the "Company"), an agricultural bioscience company, today reported financial results for the second quarter ended June 30, 2024.

Yield10 Bioscience Grants Nufarm a Commercial License to Omega-3 Assets for Producing Oil in Camelina, and Yield10 and Nufarm sign a Memorandum of Understanding for Sale of Assets
globenewswire.com17 July 2024 Sentiment: POSITIVE

WEST SACRAMENTO, Calif., July 17, 2024 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (OTC:YTEN) (“Yield10” or the “Company”), an agricultural bioscience company, today announced that the Company has signed a Memorandum of Understanding (“MOU”) and License Agreement with Nuseed Nutritional US Inc. (the seed technologies platform of Nufarm Limited (ASX:NUF)), granting Nufarm a commercial license to certain Omega-3 intellectual property assets, materials and know-how for producing oil in Camelina.

Yield10 Bioscience Grants Nufarm a Commercial License to Omega-3 Assets for Producing Oil in Camelina, and Yield10 and Nufarm sign a Memorandum of Understanding for Sale of Assets
globenewswire.com17 July 2024 Sentiment: NEGATIVE

- Nufarm to pay up to USD $5 million in consideration for the license -The parties will negotiate the sale of essentially all of Yield10's assets to Nufarm

Yield10 Bioscience Announces Addition of Camelina to INTERLINE® Herbicide Label
globenewswire.com23 May 2024 Sentiment: POSITIVE

- EPA approved an amendment to the label of INTERLINE herbicideto include Camelina -The supplemental label now allows application of INTERLINE for over-the-top weed control in Camelina WOBURN, Mass., May 23, 2024 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (OTC:YTEN) (“Yield10” or the “Company”), an agricultural bioscience company, today announced that UPL Ltd.

Yield10 Bioscience, Inc. (YTEN) Q4 2023 Earnings Call Transcript
Seeking Alpha01 April 2024 Sentiment: NEUTRAL

Yield10 Bioscience, Inc. (YTEN) Q4 2023 Earnings Call Transcript

Yield10 Bioscience to Announce Fourth Quarter and Full Year 2023 Financial Results and Host a Conference Call on Monday, April 1, 2024
GlobeNewsWire28 March 2024 Sentiment: NEGATIVE

WOBURN, Mass., March 28, 2024 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN) (“Yield10” or the “Company”), an agricultural bioscience company, today announced that the Company will report its fourth quarter and full year 2023 financial results and provide a corporate update on Monday, April 1, 2024.

Why Is Yield10 (YTEN) Stock Up 117% Today?
InvestorPlace21 March 2024 Sentiment: POSITIVE

Yield10 Bioscience (NASDAQ: YTEN ) stock is rocketing higher on Thursday after the agricultural bioscience company got new approval from the Department of Agriculture's (USDA) Biotechnology Regulatory Services (BRS). The big news here is Yield10 Bioscience's Camelina sativa varieties getting approval for breeding and growth in the U.S. This came after the agency determined the genetically modified plants don't fall under regulations 7 CFR part 340.

Why Is Yield10 Bioscience (YTEN) Stock Up 34% Today?
InvestorPlace05 February 2024 Sentiment: POSITIVE

Yield10 Bioscience (NASDAQ: YTEN ) stock is rocketing higher on Monday despite a lack of news from the U.S. agricultural bioscience company. This rally comes alongside heavy trading of YTEN stock on Monday morning.

Yield10 Bioscience, Inc. (YTEN) Q3 2023 Earnings Call Transcript
Seeking Alpha14 November 2023 Sentiment: POSITIVE

Yield10 Bioscience, Inc. (NASDAQ:YTEN ) Q3 2023 Earnings Conference Call November 14, 2023 4:30 PM ET Company Participants Lynne Brum - Investor Relations Oliver Peoples - President and Chief Executive Officer Kristi Snell - Vice President, Research and Chief Science Officer Chuck Haaser - Chief Accounting Officer Conference Call Participants Ben Klieve - Lake Street Capital Markets Noel Parks - Tuohy Brothers Operator Hello and welcome to the Third Quarter 2023 Financial Results and Business Update Conference Call for Yield10 Bioscience. [Operator Instructions] As a reminder, this conference call is being recorded.

Yield10 Bioscience to Announce Third Quarter 2023 Financial Results and Host a Conference Call on Tuesday, November 14, 2023
GlobeNewsWire08 November 2023 Sentiment: NEUTRAL

WOBURN, Mass., Nov. 08, 2023 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN) (“Yield10” or the “Company”), an agricultural bioscience company, today announced that the Company will report its third quarter 2023 financial results and provide a corporate update on Tuesday, November 14, 2023.

What type of business is Yield10 Bioscience?

Yield10 Bioscience, Inc. operates as an agricultural bioscience company that focuses on commercializing products using the Camelina oilseeds in the United States. Its products include Camelina oil for production of high levels of the omega-3 fatty acids eicosapentanoic acid (EPA) and docosahexanoic acid (DHA); and for use as a low-carbon intensity feedstock oil for biofuels, including biodiesel, renewable diesel (RD), and sustainable aviation fuel (SAF). The company was formerly known as Metabolix, Inc. and changed its name to Yield10 Bioscience, Inc. in January 2017. Yield10 Bioscience, Inc. was incorporated in 1992 and is headquartered in Woburn, Massachusetts.

What sector is Yield10 Bioscience in?

Yield10 Bioscience is in the Basic Materials sector

What industry is Yield10 Bioscience in?

Yield10 Bioscience is in the Agricultural Inputs industry

What country is Yield10 Bioscience from?

Yield10 Bioscience is headquartered in United States

When did Yield10 Bioscience go public?

Yield10 Bioscience initial public offering (IPO) was on 10 November 2006

What is Yield10 Bioscience website?

https://www.yield10bio.com

Is Yield10 Bioscience in the S&P 500?

No, Yield10 Bioscience is not included in the S&P 500 index

Is Yield10 Bioscience in the NASDAQ 100?

No, Yield10 Bioscience is not included in the NASDAQ 100 index

Is Yield10 Bioscience in the Dow Jones?

No, Yield10 Bioscience is not included in the Dow Jones index

When was Yield10 Bioscience the previous earnings report?

No data

When does Yield10 Bioscience earnings report?

The next expected earnings date for Yield10 Bioscience is 14 November 2024